• Ravindra Kolhe, MD, PhD • David Fabrizio, PhD • John Jiang, PhD • Yves Konigshofer, PhD •
verfügbar auf genomeweb
verfügbar auf genomeweb
• Prognostication of Chronic Lymphocytic Leukemia (CLL) using NGS
• Evaluation of Strategies to Leverage NGS-based Minimal Residual Disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)
• Evaluation of Strategies to Leverage NGS-based Minimal Residual Disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)
- Tumor Profiling - Liquid Biopsy -Immunonkologie